Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Geron Corp banner

Geron Corp
LSE:0IV3

Watchlist Manager
Geron Corp Logo
Geron Corp
LSE:0IV3
Watchlist
Price: 1.23 USD -1.6%
Market Cap: $21.3B
Write Note Create Alert Ask AI

Bankruptcy Probability

Geron Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Probability of Bankruptcy
LOCKED
Unlock

Financial Position

Cash & Short-Term Investments
+
3Y
-19%
5Y
+52%
10Y
+172%
Long-Term Investments
+
3Y
-15%
5Y
-40%
10Y
-5%
Debt
+
3Y
+461%
5Y
+566%
10Y
-

Solvency Ratios

Solvency Ratios Comparison
Geron Corp Competitors

Country Company Market Cap D/E D/A Interest
Coverage 		Altman
Z-Score 		Quick
Ratio 		Current
Ratio 		Cash
Ratio
US
Geron Corp
NASDAQ:GERN
803.1m USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
AbbVie Inc
NYSE:ABBV
470.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
226.2B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences, Inc
NASDAQ:GILD
188.9B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.7B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Moderna Inc
NASDAQ:MRNA
78.7B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.8B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87.3B AUD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
53.1B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Natera Inc
NASDAQ:NTRA
59.1B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Revolution Medicines Inc
NASDAQ:RVMD
43.2B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Continue 0IV3 Research

Summary
0IV3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
0IV3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0IV3 stock valuation using valuation multiples.
Wall St Estimates
0IV3 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0IV3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Geron Corp listings:
NASDAQ • USD
GERN
 F • EUR
GON
 SWB • EUR
GON
Discover More
Is Geron Corp at risk of bankruptcy?

Geron Corp's probability of bankruptcy is Hidden .

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Geron Corp have?

As of the latest report, Geron Corp has total debt of 229.1m USD. This includes both short-term (0 USD) and long-term (229.1m USD) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
ALPHA SPREAD
Follow us
Join 359,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.